Premium
Thiadiazole‐based Thioglycosides as Sodium‐glucose Co‐transporter 2 (SGLT2) Inhibitors
Author(s) -
Gao Yunlong,
Zhao Guilong,
Liu Wei,
Wang Yuli,
Xu Weiren,
Wang Jianwu
Publication year - 2010
Publication title -
chinese journal of chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 41
eISSN - 1614-7065
pISSN - 1001-604X
DOI - 10.1002/cjoc.201090120
Subject(s) - chemistry , d glucose , phenylacetic acid , in vivo , sodium , combinatorial chemistry , pharmacology , organic chemistry , medicine , microbiology and biotechnology , biology
A series of thiadiazole‐based thioglycosides were synthesized as SGLT2 inhibitors from D ‐glucose, D ‐galactose and a variety of phenylacetic acids via a convenient protocol in 8 steps and evaluated in vivo with an oral glucose tolerance test (OGTT), and 5‐benzyl‐1,3,4‐thiadiazol‐2‐yl 1‐thio‐ β ‐ D ‐glucopyranoside ( 1a ) was the most efficacious to suppress the blood glucose excursion during OGTT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom